Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

NCT00496054 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC